
The Cooper Companies, Inc.
The Cooper Companies, Inc. is a United States-based company in the Healthcare sector with a market capitalisation of $11.1B. Its FinScore is 61/100; its highest-scoring layer is Value (68) and its lowest is Momentum (36). The shares trade at 19.3x trailing earnings and are down 29% year to date.
Share price performance
About The Cooper Companies, Inc.
www.coopercos.comThe Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses such as toric for astigmatism, multifocal for presbyopia, and specialized options addressing myopia, dry eyes, and eye fatigue. These vision correction solutions are available across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Meanwhile, CooperSurgical is dedicated to women's and family health, providing a wide array of medical devices, fertility treatments, genetic testing, diagnostic tools, and contraceptives to healthcare providers and patients globally. This segment's offerings encompass various surgical and office-based products like PARAGARD (an IUD), uterine manipulators, retractors, and closure devices. It also delivers comprehensive fertility services, including specialized consumables, equipment, embryo services, and preimplantation genetic screening. Established in 1958, The Cooper Companies, Inc. is headquartered in San Ramon, California.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- HQ
- United States
- Fiscal year-end
- October
- Trading currency
- USD
- Reporting currency
- USD
- Fundamentals updated
- 7 days ago
- Market cap
- $11.1B
- Shares outstanding
- 190.2M
- P/E (TTM)
- 19.3x
- Beta (issuer)
- 0.82
- Revenue (latest FY)
- $4.1B
Revenue breakdown
- Coopervision Segment67.0%$2.7B
- Coopersurgical Segment33.0%$1.3B
FinScore
As of 2026-10-19Snapshot
Ownership
As of 2026-06-30Sign up or log in to see Analysis
Analysis for The Cooper Companies, Inc. is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Financials
Financials for The Cooper Companies, Inc. is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Estimates
Estimates for The Cooper Companies, Inc. is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Peers
Peers for The Cooper Companies, Inc. is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Valuation
Valuation for The Cooper Companies, Inc. is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see News
News for The Cooper Companies, Inc. is available to Finryse members. The Overview stays open to everyone; creating an account is free.